Druggable Targets and Compounds with Both Antinociceptive and Antipruritic Effects

被引:0
|
作者
Weng, Hao-Jui [1 ,2 ,3 ]
Quoc Thao Trang Pham [3 ,4 ]
Chang, Chia-Wei [2 ]
Tsai, Tsen-Fang [5 ]
机构
[1] Taipei Med Univ, Shuang Ho Hosp, Dept Dermatol, New Taipei 23561, Taiwan
[2] Taipei Med Univ, Coll Med, Sch Med, Dept Dermatol, Taipei 11031, Taiwan
[3] Taipei Med Univ, Coll Med, Int PhD Program Cell Therapy & Regenerat Med, Taipei 11031, Taiwan
[4] Univ Med & Pharm Ho Chi Minh City, Fac Med, Dept Dermatol, Ho Chi Minh City 70000, Vietnam
[5] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei 100225, Taiwan
关键词
pain; pruritus; neuropathy; NERVE GROWTH-FACTOR; ACTIVATED RECEPTOR 2; TOXIN TYPE-A; HISTAMINE-INDUCED ITCH; OPIOID-INDUCED ITCH; ATOPIC-DERMATITIS; NEUROPATHIC PAIN; SECONDARY HYPERALGESIA; DOUBLE-BLIND; POSTHERPETIC NEURALGIA;
D O I
10.3390/ph15070892
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Pain and itch are both important manifestations of various disorders, such as herpes zoster, atopic dermatitis, and psoriasis. Growing evidence suggests that both sensations have shared mediators, overlapping neural circuitry, and similarities in sensitization processes. In fact, pain and itch coexist in some disorders. Determining pharmaceutical agents and targets for treating pain and itch concurrently is of scientific and clinical relevance. Here we review the neurobiology of pain and itch and discuss the pharmaceutical targets as well as novel compounds effective for the concurrent treatment of these sensations.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] Antipruritic effects of pimecrolimus and tacrolimus
    Ständer, S
    Luger, TA
    HAUTARZT, 2003, 54 (05): : 413 - 417
  • [22] ANTIPRURITIC EFFECTS OF A NEW PHARMACEUTICAL
    ROUGRAFF, ME
    PENNSYLVANIA MEDICAL JOURNAL, 1961, 64 (07): : 874 - &
  • [23] Glial Cells and Itch: Possible Targets for Novel Antipruritic Therapies
    Gao, Xinyi
    Wang, Zhifei
    Du, Lixia
    ACS CHEMICAL NEUROSCIENCE, 2023, 14 (03): : 331 - 339
  • [24] Antinociceptive and sedative effects of buprenorphine, acepromazine, or combination of both, in conscious cats
    Santana, Luciana Alvarez
    Loureiro Luna, Stelio Pacca
    Steagall, Paulo Vinicius Mortensen
    Ferreira, Tatiana Henriques
    Taylor, Polly
    Dixon, Mike
    CIENCIA RURAL, 2010, 40 (10): : 2122 - 2128
  • [25] AN OUTLOOK ON DRUGGABLE TARGETS TO COMBAT PANCREATIC DUCTALADENOCARCINOMA
    Rashmi, B. Aarthi
    Harishchander, A.
    Sivaraman, Thirunavukkarasu
    INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2020, : 98 - 102
  • [26] Druggable Targets of Squamous Cell Lung Cancer
    Kim, Cheol Hyeon
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2013, 75 (06) : 231 - 235
  • [27] Phosphatases are emerging as novel druggable targets in Plasmodium
    Khalife, Jamal
    Pierrot, Christine
    FUTURE MICROBIOLOGY, 2016, 11 (05) : 603 - 606
  • [28] Toxoplasmosis: Current and Emerging Parasite Druggable Targets
    Hajj, Rana El
    Tawk, Lina
    Itani, Shaymaa
    Hamie, Maguy
    Ezzeddine, Jana
    El Sabban, Marwan
    El Hajj, Hiba
    MICROORGANISMS, 2021, 9 (12)
  • [29] Cysteine metabolic circuitries: druggable targets in cancer
    Bonifacio, Vasco D. B.
    Pereira, Sofia A.
    Serpa, Jacinta
    Vicente, Joao B.
    BRITISH JOURNAL OF CANCER, 2021, 124 (05) : 862 - 879
  • [30] Novel Biology and Druggable Targets via Chemoproteomics
    Saghatelian, Alan
    BIOCHEMISTRY, 2017, 56 (50) : 6515 - 6516